Dice CEO: Energy, T...
Escalon Medical Corporation (ESMC: NASDAQ)
$0.60 -0.10 | -14.29%
06/01/12 - 03:19 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 25.70 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | 49.70 | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | 19.70 | 12.50 |
| Beta | 0.25 | 0.83 | 0.98 |
| Price to Sales (TTM) | 0.17 | 2.60 | 1.42 |
| Price to Book (MRQ) | 2.82 | 2.62 | 2.41 |
| Price to Tangible Book (MRQ) | 6.85 | 10.66 | 5.08 |
| Price to Cash Flow (TTM) | -0.70 | 15.40 | 9.80 |
| Price to Free Cash Flow (TTM) | -3.00 | 35.90 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 1.70 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.70 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 12.44 | -0.76 |
| Payout Ratio (TTM) | 0.00 | 20.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | -19.10 | 12.60 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | -5.40 | 20.70 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | -5.56 | 11.49 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 10.30 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | 10.30 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | 8.89 | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | -6.80 | 4.24 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 0.50 | 1.90 | 1.10 |
| Current Ratio (MRQ) | 1.10 | 2.80 | 1.60 |
| LT Debt to Equity (MRQ) | 0.00 | 0.30 | 0.82 |
| Total Debt to Equity (MRQ) | 2.78 | 0.35 | 0.96 |
| Interest Coverage (TTM) | n.a. | 14.90 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 40.00 | 70.50 | 46.90 |
| Gross Margin - 5 Yr Avg | 49.30 | 69.30 | 47.70 |
| EBITD Margin (TTM) | -13.00 | 28.60 | 18.90 |
| EBITD - 5 Yr Avg | 0.42 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | -18.20 | 18.50 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | -19.40 | 15.70 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -0.17 | 0.14 | 0.09 |
| Net Profit Margin - 5 Yr Avg | -17.10 | 11.10 | 7.00 |
| Return on Assets (TTM) | -67.20 | 8.40 | 3.10 |
| Return on Assets - 5 Yr Avg | -20.00 | 7.30 | 2.50 |
| Return on Investment (TTM) | -443.00 | 10.90 | 7.90 |
| Return on Investment - 5 Yr Avg | -26.40 | 9.60 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 169,162.00 | 414,937.00 | 449,376.00 |
| Net Income/Employee (TTM) | -44,955.00 | 56,730.00 | 39,003.00 |
| Receivable Turnover (TTM) | 6.60 | 5.10 | 7.60 |
| Inventory Turnover (TTM) | 2.60 | 2.10 | 8.30 |
| Asset Turnover (TTM) | 1.80 | 0.70 | 0.40 |
Portfolios with ESMC
- Portfolio NameUser Type
- Usermoonrakr Portfolio 1
- UserSUPRATRADE " ALL STAR ...
- Userpmosbacher Portfolio 1
- Userrobichatterji Portfolio 1
- UserAnnrc Portfolio 1
Latest ESMC Headlines from TheStreet
- TSC Ratings' Updates: Allergan 09.17.08 | 06:09 am
- Tuesday's Winners & Losers: Earnings Can't Boost Goldman 12.18.07 | 04:12 pm
- Tuesday's Health Winners & Losers 12.18.07 | 04:12 pm
- Today's Small-Cap Winners and Losers 02.14.06 | 02:02 pm
- Health Stocks in Motion 05.17.05 | 04:05 pm
- Escalon Down on Placement 03.17.04 | 05:03 pm
Press Releases for ESMC
- Sonomed Escalon⢠Announces Release Of AXIS⢠IPad App - PR Newswire 02.23.12 | 05:02 pm
- Sonomed Escalon⢠Introduces VuMAX⢠Auto Tracking Feature - PR Newswire 02.23.12 | 04:02 pm
- Escalon Announces That The Restructuring Of Its IVD Business Is Largely Completed - PR Newswire 02.23.12 | 04:02 pm
- Escalon® Announces The Refinancing Of Its Debt - PR Newswire 05.05.11 | 09:05 am
- Escalon(R) Medical Corp. Divest Of Its Vascular Access Product Line - PR Newswire 05.03.10 | 08:05 am
Partner Headlines for ESMC
- Escalon Announces That the Restructuring of Its IVD Business is Largely Completed - Benzinga 02.23.12 | 04:02 pm
- Morning Market Losers - Benzinga 10.24.11 | 09:10 am





